← Back
Data updated: Mar 10, 2026
CHENGDU SHUODE
Cardiovascular
CHENGDU SHUODE is a generic drug manufacturer focused on Cardiovascular.
2023
Since
3
Drugs
-
Trials
17
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METHYLENE BLUE 2026-02-02
Manufacturing (CMC)
METHYLENE BLUE 2025-12-23
NICARDIPINE HYDROCHLORIDE 2025-12-18
Manufacturing (CMC)
NICARDIPINE HYDROCHLORIDE 2025-10-28
NICARDIPINE HYDROCHLORIDE 2025-08-20
METHYLENE BLUE 2025-07-30
NICARDIPINE HYDROCHLORIDE 2025-06-25
NICARDIPINE HYDROCHLORIDE 2025-05-09
Labeling
NICARDIPINE HYDROCHLORIDE 2025-04-17
Labeling
METHYLENE BLUE 2025-03-04
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2023-11-15
- Latest
- 2025-12-23
- Applications
- 3